In a retrospective review of the patients evaluated at the Mayo Clinic from January 1998 to March 2011, only eight patients with vasculitis associated with anti-TNF therapy were identified, and, of these, only four had IBD [3]. The gene discussed is TNF; the disease is vasculitis.